Impact of a new dosing regimen of epoetin alfa on quality of life and anemia in patients with low-risk myelodysplastic syndrome - Concepedia

Concepedia

Publication | Closed Access

Impact of a new dosing regimen of epoetin alfa on quality of life and anemia in patients with low-risk myelodysplastic syndrome

110

Citations

35

References

2004

Year

Maria Antonietta Aloe Spiriti, Roberto Latagliata, Pasquale Niscola, Agostino Cortelezzi, Marta Francesconi, Daris Ferrari, E Volpe, Marino Clavio, Alberto Grossi, M. Tambone Reyes,

Annals of Hematology

Hematological MalignancyBone Marrow FailureMedicineEpoetin AlfaHematologyPharmacotherapyLow-risk Myelodysplastic SyndromePharmacologyAplastic AnemiaMyeloid Neoplasia

References

	Year	Citations

Page 1

Page 1